Home      About this journal      Authors      Editors      Readers      Archive      Contact us
An outlook on research and development of multi-target, synergistic acting anti-arrhythmia compound medicine: progress and case study of Wenxin Keli
Hits 5573  Download times 2326  Received:September 13, 2016  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2017.01.04
Key Words   Wenxin Keli;arrhythmia;pharmacological mechanism;ion channel;electrophysiology
Author NameAffiliationE-mail
WANG Tai-yi Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Research and Development Center of Traditional Chinese Medicine, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China 
 
YAO Xi Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Research and Development Center of Traditional Chinese Medicine, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China 
 
XIE Wei-wei Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Research and Development Center of Traditional Chinese Medicine, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China 
 
CUI Ying Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Research and Development Center of Traditional Chinese Medicine, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China 
 
ZHU Yan Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Research and Development Center of Traditional Chinese Medicine, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China 
yanzhu.harvard@icloud.com 
Abstract
    Wenxin Keli (WK), a Chinese patent medicine, is known to be effective for cardiac arrhythmias and heart failure. According to traditional Chinese medicine theory, WK is suitable for treating Yin deficiency, systolic blood stasis of heart palpitations, and pulse knot generation. Symptoms refer shortness of breath, fatigue, restlessness, palpitations, dizziness, irritability, chest pain, pulse knot generation or imaginary. pharmacological investigations on WK has been on going, particularly with some of the most important findings achieved recently. In this paper, we summarize the research progress of WK pharmacology to date, focusing on cardiac electrophysiological discoveries, and discuss the rationality and need of a multi-target, coordinative regulation capability ofantiarrhythmiccompound medicine.

You are the 2307069 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.